Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Daiichi Sankyo
Fuji
Accenture
Colorcon
Harvard Business School
QuintilesIMS
AstraZeneca
Federal Trade Commission
Boehringer Ingelheim

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,291,445

« Back to Dashboard

Summary for Patent: 6,291,445
Title: Low dose budesonide formulations and uses thereof
Abstract:A metered unit dose comprising 40 .mu.g or less of budesonide is disclosed, as well as formulations thereof, and the use thereof for the treatment of nasal conditions.
Inventor(s): Nilsson; Hans (Lund, SE), Santesson; Gordon (Horby, SE)
Assignee: Astra Aktiebolag (Sodertalje, SE)
Application Number:08/846,960
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 6,291,445

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,291,445

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9604486Dec 05, 1996

International Patents Family Members for US Patent 6,291,445

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 239482 ➤ Subscribe
Austria 369118 ➤ Subscribe
Australia 5421198 ➤ Subscribe
Australia 726515 ➤ Subscribe
Belgium 1011394 ➤ Subscribe
Canada 2243083 ➤ Subscribe
China 1168450 ➤ Subscribe
China 1210467 ➤ Subscribe
Czech Republic 295792 ➤ Subscribe
Czech Republic 9802437 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Teva
Baxter
UBS
Boehringer Ingelheim
McKinsey
Johnson and Johnson
Express Scripts
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot